Literature DB >> 20859126

Evaluation and treatment of stage I and II thymoma.

Frank C Detterbeck1.   

Abstract

Thymomas are relatively uncommon. Nevertheless, an accumulation of studies (mostly retrospective, single-institution series) have made it important to approach this disease in a knowledgeable, evidence-based fashion. This begins with the approach to evaluation of a patient with an anterior mediastinal mass, in whom a reliable clinical diagnosis is usually possible in experienced centers. Surgical resection is the mainstay of treatment, and every effort must be made to achieve a complete resection.

Entities:  

Mesh:

Year:  2010        PMID: 20859126     DOI: 10.1097/JTO.0b013e3181f20dab

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN: 1556-0864            Impact factor:   15.609


  21 in total

1.  The International Association for the Study of Lung Cancer/the International Thymic Malignancies Interest Group proposal for the TNM staging systems for thymic epithelial tumors and large-scale retrospective data.

Authors:  Kazuya Kondo
Journal:  J Thorac Dis       Date:  2016-08       Impact factor: 2.895

2.  Multimodality treatment of stage II thymic tumours.

Authors:  Carolina Carillo; Daniele Diso; Sara Mantovani; Ylenia Pecoraro; Tiziano De Giacomo; Anna Maria Ciccone; Camilla Poggi; Flavia Longo; Raffaele Cassese; Vincenzo Tombolini; Erino Angelo Rendina; Federico Venuta; Marco Anile
Journal:  J Thorac Dis       Date:  2017-08       Impact factor: 2.895

3.  Recurrent Thymoma in the Retroperitoneal Space: A Rare Case Report.

Authors:  Jun Yang; Qin-Qing Li; Ying-Ying Ding; Liao Cheng-de
Journal:  Clin Pract       Date:  2015-06-17

4.  Comparative study of video-assisted thoracic surgery versus open thymectomy for thymoma in one single center.

Authors:  Zu-Yang Yuan; Gui-Yu Cheng; Ke-Lin Sun; You-Sheng Mao; Jian Li; Yong-Gang Wang; Da-Li Wang; Shu-Geng Gao; Qi Xue; Jin-Feng Huang; Ju-Wei Mu
Journal:  J Thorac Dis       Date:  2014-06       Impact factor: 2.895

5.  Myasthenia gravis in patients with thymoma affects survival rate following extended thymectomy.

Authors:  Zhefeng Zhang; Youbin Cui; Rui Jia; Lei Xue; Huagang Liang
Journal:  Oncol Lett       Date:  2016-05-05       Impact factor: 2.967

Review 6.  [Thymus cancers: A clinical observation].

Authors:  H Grosch; H Hoffmann; C-A Weis; M Thomas
Journal:  Pathologe       Date:  2016-02       Impact factor: 1.011

7.  Octreotide in the treatment of malignant thymoma - Case report.

Authors:  Ondrej Sorejs; Milos Pesek; Jindrich Finek; Ondrej Fiala
Journal:  Rep Pract Oncol Radiother       Date:  2020-08-25

8.  Is There a Role of Postoperative Radiation Therapy in Completely Resected Stage I/II Thymic Epithelial Tumor?

Authors:  Dongryul Oh; Yong Chan Ahn; Kwhanmien Kim; Jhingook Kim; Young Mog Shim; Jungho Han
Journal:  Cancer Res Treat       Date:  2012-09-30       Impact factor: 4.679

9.  Predictors of recurrence after thymoma resection.

Authors:  Mi Kyung Bae; Chang Young Lee; Jin Gu Lee; In Kyu Park; Dae Joon Kim; Woo Ick Yang; Kyung Young Chung
Journal:  Yonsei Med J       Date:  2013-07       Impact factor: 2.759

10.  Wnt4 overexpression promotes thymoma development through a JNK-mediated planar cell polarity-like pathway.

Authors:  Yuan Chen; Peng Zhang; Peiyuan Tang; Peng Lv; Xin Li; Yuanguo Wang; Yang Lv; Yimei Liu
Journal:  Oncol Lett       Date:  2017-10-25       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.